GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Gross Profit

SanBio Co (TSE:4592) Gross Profit : 円0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Gross Profit?

SanBio Co's gross profit for the three months ended in Jan. 2024 was 円0.00 Mil. SanBio Co's gross profit for the trailing twelve months (TTM) ended in Jan. 2024 was 円0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. SanBio Co's gross profit for the three months ended in Jan. 2024 was 円0.00 Mil. SanBio Co's Revenue for the three months ended in Jan. 2024 was 円0.00 Mil. Therefore, SanBio Co's Gross Margin % for the quarter that ended in Jan. 2024 was N/A%.

SanBio Co had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage

During the past 11 years, the highest Gross Margin % of SanBio Co was 98.19%. The lowest was 98.19%. And the median was 98.19%.


SanBio Co Gross Profit Historical Data

The historical data trend for SanBio Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Gross Profit Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 447.23 - - - -

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SanBio Co's Gross Profit

For the Biotechnology subindustry, SanBio Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where SanBio Co's Gross Profit falls into.



SanBio Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

SanBio Co's Gross Profit for the fiscal year that ended in Jan. 2024 is calculated as

Gross Profit (A: Jan. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

SanBio Co's Gross Profit for the quarter that ended in Jan. 2024 is calculated as

Gross Profit (Q: Jan. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

SanBio Co's Gross Margin % for the quarter that ended in Jan. 2024 is calculated as

Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SanBio Co  (TSE:4592) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SanBio Co had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


SanBio Co Gross Profit Related Terms

Thank you for viewing the detailed overview of SanBio Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (TSE:4592) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines